Mirae Tiger Securities ETF (157500)

Overview

Hybrigenics SA is a prominent biotechnology firm based in Gallargues-le-Montueux, France, operating under the umbrella of its parent company, Diagnostic Medical Systems S.A. Specializing in the realms of biotechnology, oncology, regenerative medicine, and anti-aging medicine, Hybrigenics SA plays a crucial role in advancing research and development within these sectors. Through its commitment to innovation and the exploration of new frontiers in science and medicine, the company stands at the forefront of biotechnological progress, driving advancements that promise to reshape our understanding and treatment of various health conditions and diseases.

Products and Services

• Biotechnology Development

  Hybrigenics SA leverages cutting-edge biotechnological processes to create novel solutions aimed at addressing critical challenges in healthcare. The company's focus spans a broad spectrum, including drug discovery, the development of therapeutic proteins, and the improvement of genetic engineering techniques, all aimed at combating diseases and enhancing human health.

• Oncology Research

  In the field of oncology, Hybrigenics is dedicated to discovering and developing innovative cancer treatments. This involves the exploration of new therapeutic targets, the advancement of specific cancer therapies, and the investigation into the mechanisms of tumor development and progression. By pushing the boundaries of current knowledge, the company contributes significantly to the fight against cancer.

• Regenerative Medicine

  Hybrigenics SA is also active in regenerative medicine, focusing on the development of therapies that restore, maintain, or improve tissue and organ function lost due to age, disease, damage, or congenital defects. Utilizing adipose tissue cells and stem cells, the company's research aims to pioneer treatments that can potentially revolutionize the approach to healing and recovery in various medical conditions.

• Anti-Aging Medicine

  The company's anti-aging research efforts are dedicated to uncovering and developing treatments that slow down, halt, or reverse the aging process. Through a detailed understanding of the biological mechanisms underlying aging, Hybrigenics seeks to innovate preventative strategies and therapies that promote longevity and enhance the quality of life.

• Technical Solutions Using Adipose Tissue Cells and Stem Cells

  Hybrigenics SA excels in the application of adipose tissue cells and stem cells for medical treatments, offering technical solutions that harness the potential of these cells for therapeutic purposes. This includes the development of procedures for the isolation, multiplication, and application of these cells in various domains of medicine, paving the way for advanced treatment options that leverage the body's inherent healing capabilities.